Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ADAM17-mediated EGFR ligand shedding directs macrophage-promoted cancer cell invasion
Sebastian P. Gnosa, Laia Puig Blasco, Krzysztof B. Piotrowski, Marie L. Freiberg, Simonas Savickas, Daniel H. Madsen, Ulrich auf dem Keller, Pauliina Kronqvist, Marie Kveiborg
Sebastian P. Gnosa, Laia Puig Blasco, Krzysztof B. Piotrowski, Marie L. Freiberg, Simonas Savickas, Daniel H. Madsen, Ulrich auf dem Keller, Pauliina Kronqvist, Marie Kveiborg
View: Text | PDF
Research Article Oncology

ADAM17-mediated EGFR ligand shedding directs macrophage-promoted cancer cell invasion

  • Text
  • PDF
Abstract

Macrophages in the tumor microenvironment have a substantial impact on tumor progression. Depending on the signaling environment in the tumor, macrophages can either support or constrain tumor progression. It is therefore of therapeutic interest to identify the tumor-derived factors that control macrophage education. With this aim, we correlated the expression of A Disintegrin and Metalloproteinase (ADAM) proteases, which are key mediators of cell-cell signaling, to the expression of protumorigenic macrophage markers in human cancer cohorts. We identified ADAM17, a sheddase upregulated in many cancer types, as a protein of interest. Depletion of ADAM17 in cancer cell lines reduced the expression of several protumorigenic markers in neighboring macrophages in vitro as well as in mouse models. Moreover, ADAM17–/– educated macrophages demonstrated a reduced ability to induce cancer cell invasion. Using mass spectrometry–based proteomics and ELISA, we identified heparin-binding EGF (HB-EGF) and amphiregulin, shed by ADAM17 in the cancer cells, as the implicated molecular mediators of macrophage education. Additionally, RNA-Seq and ELISA experiments revealed that ADAM17-dependent HB-EGF ligand release induced the expression and secretion of CXCL chemokines in macrophages, which in turn stimulated cancer cell invasion. In conclusion, we provide evidence that ADAM17 mediates a paracrine EGFR-ligand-chemokine feedback loop, whereby cancer cells hijack macrophages to promote tumor progression.

Authors

Sebastian P. Gnosa, Laia Puig Blasco, Krzysztof B. Piotrowski, Marie L. Freiberg, Simonas Savickas, Daniel H. Madsen, Ulrich auf dem Keller, Pauliina Kronqvist, Marie Kveiborg

×

Figure 6

Chemokine secretion from macrophages is responsible for enhanced cell invasion.

Options: View larger image (or click on image) Download as PowerPoint
Chemokine secretion from macrophages is responsible for enhanced cell in...
(A) Experimental setup for RNA-Seq of BMDMs upon coculture with cancer cells (B and C). (B) Volcano plot of mRNA transcripts detected by RNA-Seq in BMDMs educated by WT or Adam17–/– (A17–/–) 4T1 cells. Upregulated genes are indicated in red and downregulated genes in blue. DEGs, differentially expressed genes. (C) KEGG pathways of significantly upregulated and downregulated genes detected by RNA-Seq, using the g:Profiler tool. (D) Relative CXCL1 secretion in WT or Adam17–/– 4T1 and E0771 cells cocultured with BMDMs and analyzed by ELISA (n = 3). (E) CXCL1 secretion in WT and Adam17–/– 4T1 and E0771 cells cocultured with BMDMs or alone, determined by ELISA (n = 3). (F) Experimental setup of Boyden chamber invasion assays, using solvent (NC) or rCXCL1 as chemoattractant. (G) Average number of invaded cells/field of 4T1 and E0771 cell lines (n = 3). (H) Experimental setup of Boyden chamber invasion assays. (I) Relative invasion of 4T1 and E0771 cells cocultured with polarized macrophages and subjected to the CXCR2 inhibitor SB225002 (n = 3). Mean and standard deviation indicated. Data in E were analyzed by 1-way ANOVA with Dunnett’s multiple comparison test, and data in D, G, and I were analyzed using 2-sided, unpaired Student’s t test; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts